Physician
Wang, Roger
Wang, Roger was paid $649K by Medicaid between Jan 2018 and Oct 2024, across 27 billing codes. Its largest line is 20610, — 27% of everything it billed.
33Billing provider infoWANG, ROGER
SAN FRANCISCO, CA 94108
SAN FRANCISCO, CA 94108
33aNPI1164522165assigned 09/22/2006
33bProvider typeInternal Medicine Physician
28Total paid$649K
24GClaims36,650
24DCodes billed27
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#193 of 2,679
Median peer was paid$13K
This provider vs. median51×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,984 | $14K | |
| 2019 | 6,388 | $15K | |
| 2020 | 6,676 | $64K | |
| 2021 | 6,797 | $164K | |
| 2022 | 5,616 | $106K | |
| 2023 | 4,259 | $231K | |
| 2024incomplete | 930 | $55K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 20610 | 27% | 5,911 | 3,134 | $176K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 5,664 | 5,278 | $162K |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 18% | 661 | 265 | $117K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 11% | 1,588 | 1,538 | $72K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 9.8% | 373 | 176 | $64K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.2% | 3,006 | 1,592 | $27K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 1.9% | 1,788 | 1,614 | $12K |
| 94760 | <1% | 4,106 | 3,686 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 617 | 385 | $5K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | <1% | 2,049 | 1,076 | $4K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 1,698 | 701 | $2K |
| 99245 | <1% | 15 | 15 | $735.84 |
15 more codes
| 95115 | <1% | 1,708 | $527.88 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 48 | $75.32 |
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | <1% | 19 | $70.72 |
| 4192F | 0% | 994 | $0.00 | |
| 3476F | 0% | 775 | $0.00 | |
| 3455F | 0% | 688 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 195 | $0.00 |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 0% | 13 | $0.00 |
| 3470F | 0% | 13 | $0.00 | |
| 4195F | 0% | 775 | $0.00 | |
| M1003 | Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy | 0% | 953 | $0.00 |
| 1006F | 0% | 642 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 362 | $0.00 |
| M1007 | >=50% of total number of a patient's outpatient ra encounters assessed | 0% | 994 | $0.00 |
| 1170F | 0% | 995 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.